Cannabinoids do not reduce objective measurements in muscle spasticity, but people with multiple sclerosis perceive some benefit
Franjo GrotenhermenVolume:
8
Year:
2004
Language:
english
Pages:
3
DOI:
10.1016/j.ehbc.2004.03.014
File:
PDF, 139 KB
english, 2004